Skip to main content

Advertisement

SpringerLink
Log in

Enteral Nutrition as a Primary Therapy for Intestinal Lymphangiectasia: Value of Elemental Diet and Polymeric Diet Compared with Total Parenteral Nutrition

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Intestinal lymphangiectasia (IL) is a rare disease requiring oral fat restriction. The aim of this study was to evaluate the efficacy of enteral nutrition compared to that of total parenteral nutrition (TPN). We retrospectively reviewed nine patients with IL presenting with protein-losing enteropathy. Of these, seven patients not responding to a low-fat diet were treated with elemental diet (ED), polymeric diet (PD) containing medium-chain triglycerides, or TPN. Improvement in serum total protein was observed in two of three on ED and in one of two on PD, compared with three of three on TPN. Enteric protein loss was improved in two of two on ED, one of two on PD, and two of two on TPN. Outpatients who continued to receive enteral nutrition maintained a total protein level. Enteral nutirition appears to be as effective as TPN for patients with IL, and it may provide a valid and safe alternative therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jeffries GH, Chapman A, Sleisenger MH: Low-fat diet in intestinal lymphangiectasia. Its effects on albumin metabolism. N Engl J Med 270:761–766, 1965

    Google Scholar 

  2. Yssing M, Jensen H, Jarnum S: Dietary treatment of protein-losing enteropathy. Acta Paediatr Scand 56:173–181, 1967

    PubMed  Google Scholar 

  3. Alfano V, Tritto G, Alfonsi L, Cella A, Pasanisi F, Contaldo F: Stable reversal of pathologic signs of primitive intestinal lymphangiectasia with a hypolipidic, MCT-enriched diet. Nutrition 16:303–304, 2000

    Article  PubMed  Google Scholar 

  4. Amirhakimi GH, Samloff M, Bryson MF, Forbes GB: Intestinal lymphangiectasia. Metabolic studies. Am J Dis Child 117:178–185, 1969

    PubMed  Google Scholar 

  5. Fleisher TA, Strober W, Muchmore AV, Broder S, Krawitt EL, Waldmann TA: Corticosteroid-responsive intestinal lymphangiectasia secondary to an inflammatory process. N Engl J Med 300:605–606, 1979

    PubMed  Google Scholar 

  6. Rubin DC: Small intestine: anatomy and structural anomalies. Lymphangiectasia. In (ed) Textbook of Gastroenterology, 3rd ed. Yamada T, ed. Philadelphia, Lippincott Williams & Wilkins, 1999, pp 1578–1579

    Google Scholar 

  7. Vardy PA, Lebenthal E, Shwachman H: Intestinal lymphangiectasia: a reappraisal. Pediatrics 55:842–851, 1975

    PubMed  Google Scholar 

  8. Goldberg RI, Calleja GA: Protein-losing gastroenteropathies. In Boccus Gastroenterology, 5th ed. Haubrich WS, Schaffner F, Berk JE (eds). Philadelphia, WB Saunders, 1995, pp 1072–1086

    Google Scholar 

  9. Aoyagi K, Iida M, Yao T, Matsui T, Okada M, Oh K, Fujishima M: Characteristic endoscopic features of intestinal lymphangiectasia: correlation with histological findings. Hepatogastroenterology 44:133–138, 1997

    PubMed  Google Scholar 

  10. Aoyagi K, Iida M, Yao T, Matsui T, Okada M, Fujishima M: Intestinal lymphangiectasia: value of double-contrast radiographic study. Clin Radiol 49:814–819, 1994

    PubMed  Google Scholar 

  11. Florent C, L’Hirondel C, Desmazures C, Aymes C, Bernier JJ: Intestinal clearance of alpha 1-antitrypsin. A sensitive method for the detection of protein-losing enteropathy. Gastroenterology. 81:777–780, 1981

    PubMed  Google Scholar 

  12. Tsuchiya M, Oshio C, Asakura H, Ishii H, Aoki I, Miyairi M: Budd–Chiari syndrome associated with protein–losing enteropathy. Gastroenterology. 75:114–117, 1978

    PubMed  Google Scholar 

  13. Edworthy SM, Fritzler MJ, Kelly JK, McHattie JD, Shaffer EA: Protein-losing enteropathy in systemic lupus erythematosus associated with intestinal lymphangiectasia. Am J Gastroenterol 85:1398–1402, 1990

    PubMed  Google Scholar 

  14. Mistilis SP, Stephen DD, Skyring AP: Intestinal lymphangiectasia. Mechanism of enteric loss of plasma-protein and fat. Lancet 1:77–81, 1965

    Article  Google Scholar 

  15. Giaffer MH, North G, Holdsworth CD: Controlled trial of polymeric versus elemental diet in treatment of active Crohn’s disease. Lancet. 335(8693):816–819, 1990

    Article  PubMed  Google Scholar 

  16. Verma S, Brown S, Kirkwood B, Giaffer MH: Polymeric versus elemental diet as primary treatment in active Crohn’s disease: a randomized, double-blind trial. Am J Gastroenterol. 95:735–739, 2000

    Article  PubMed  Google Scholar 

  17. Thompson JM, Brett A, Rose SJ: Dietary management of intestinal lymphangiectasia complicated by short gut syndrome. Hum Nut Appl Nutr 40:136–140, 1986

    Google Scholar 

  18. Rust C, Pratschke E, Hartl W, Kessler M, Weibecke B, Sauerbruch T, Paumgartner G, Beuers U: Fibrotic entrapment of the small bowel in congenital intestinal lymphangiectasia. Am J Gastroenterol 93:1980–1983, 1998

    PubMed  Google Scholar 

  19. Mine K, Matsubayashi S, Nakai Y, Nakagawa T.: Intestinal lymphangiectasia markedly improved with antiplasmin therapy. Gastroenterology 96:1596–1599, 1989

    PubMed  Google Scholar 

  20. Bac DJ, Van Hagen PM, Postema PT, ten Bokum AM, Zondervan PE, van Blankenstein M: Octreotide for protein–losing enteropathy with intestinal lymphangiectasia. Lancet 24(345):1639, 1995

    Google Scholar 

  21. Ballinger AB, Farthing MJ: Octreotide in the treatment of intestinal lymphangiectasia. Eur J Gastroenterol Hepatol 10:699–702, 1998

    PubMed  Google Scholar 

  22. Kuroiwa G, Takayama T, Sato Y, Takahashi Y, Fujita T, Nobuoka A, Kukitsu T, Kato J, Sakamaki S, Niitsu Y: Primary intestinal lymphangiectasia successfully treated with octreotide. J Gastroenterol 36:129–132, 2001

    PubMed  Google Scholar 

  23. MacLean JE, Cohen E, Weinstein M: Primary intestinal and thoracic lymphangiectasia: a response to antiplasmin therapy. Pediatrics 109:1177–1180, 2002

    PubMed  Google Scholar 

  24. Tift WL, Lloyd JK: Intestinal lymphangiectasia. Long-term results with MCT diet. Arch Dis Child 50:269–276, 1975

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Third Department of Medicine, School of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, 814-0180, Japan

    Kunihiko Aoyagi MD, Mitsuo Iida MD, Takayuki Matsumoto MD & Shotaro Sakisaka MD

  2. Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

    Kunihiko Aoyagi MD, Mitsuo Iida MD, Takayuki Matsumoto MD & Shotaro Sakisaka MD

Authors
  1. Kunihiko Aoyagi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mitsuo Iida MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takayuki Matsumoto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shotaro Sakisaka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kunihiko Aoyagi MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aoyagi, K., Iida, M., Matsumoto, T. et al. Enteral Nutrition as a Primary Therapy for Intestinal Lymphangiectasia: Value of Elemental Diet and Polymeric Diet Compared with Total Parenteral Nutrition. Dig Dis Sci 50, 1467–1470 (2005). https://doi.org/10.1007/s10620-005-2863-7

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-005-2863-7

Key Words

Search

Navigation